Detalles de la búsqueda
1.
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.
Blood
; 143(7): 592-596, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048557
2.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439329
3.
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
Eur J Nucl Med Mol Imaging
; 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795120
4.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050405
5.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Hematol Oncol
; 42(4): e3290, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38818978
6.
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience.
Ann Hematol
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805036
7.
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Am J Hematol
; 99(2): 254-262, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108611
8.
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.
Lancet Oncol
; 24(1): 64-76, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36528035
9.
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network.
Lancet Oncol
; 24(6): e255-e269, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269857
10.
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study.
Lancet Oncol
; 24(10): 1119-1133, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37717583
11.
Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort.
Br J Haematol
; 202(5): 928-936, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259629
12.
Towards a personalized preventive strategy of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an ad hoc Italian expert panel.
Haematologica
; 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105723
13.
TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition?
Hematol Oncol
; 41(5): 942-946, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37534633
14.
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
Hematol Oncol
; 41(4): 655-662, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246287
15.
A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin's lymphoma.
Ann Hematol
; 102(2): 385-392, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645458
16.
Overall and complication-free survival in a large cohort of patients with ß-thalassemia major followed over 50 years.
Am J Hematol
; 98(3): 381-387, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36588408
17.
Myeloma cells regulate miRNA transfer from fibroblast-derived exosomes by expression of lncRNAs.
J Pathol
; 256(4): 402-413, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34919276
18.
IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective.
Acta Haematol
; 146(1): 37-43, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195064
19.
The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms.
Int J Mol Sci
; 24(5)2023 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36902299
20.
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?
Int J Mol Sci
; 24(4)2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36834692